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Here we describe a case of a prenatal diagnosis of a male fetus that inherited the
unstable allele from his full mutation mosaic mother (29, 160, >200 CGG repeats)
reduced to a normal size range (19 CGG repeats). Haplotype analysis showed that
the fetus 19 CGG repeats allele derived from the maternal unstable allele which was
inherited from his maternal grandmother. No size mosaicism was detected by testing
the DNA from in vitro cultured samples, including seventh passage culture as well as
from two amniocentesis samples. Sequence analysis confirmed that the allele was 19
CGG repeats long. Methylation assay showed no methylation. Although none of the
techniques used in this study can provide with absolute certainty the diagnosis, the
results strongly indicate the presence in the fetus of an allele with a CGG repeat number
in the normal range. Because this is a prenatal diagnosis case, the crucial question is
whether the 19 CGG allele derived from the maternal unstable expanded allele, which
contracted to the normal range, became a normal stable allele or a normal unstable allele
which could expand in the next generation. It is also possible that allele size mosaicism
of the FMR1 gene that went undetected exists. Because this is a prenatal diagnosis
case, we cannot with certainty exclude the presence of an undetected expanded allele
of the FMR1 gene, in addition to the 19 CGG allele derived from an unstable expanded
allele, which contracted to the normal range.
Keywords: prenatal diagnosis, FMR1 gene, instability, expansion, contraction
INTRODUCTION
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the
most common monogenic cause of Autism Spectrum Disorders (Harris et al., 2008). The FXS
is caused by a dynamic mutation in the FMR1 gene, which is located at Xq27.3. A normal gene
carries up to 54 CGG repeats in the 5′ UTR while a premutation allele carries 55–200 CGG
repeats and is considered unstable during transmission to offspring. The full mutation allele
harbors more than 200 CGG repeats and shows somatic mosaicism in 12–41% cases (Nolin et al.,
1994; Rousseau et al., 1994; Merenstein et al., 1996). Full mutation alleles are usually methylated
and transcriptionally silent so that no FMR1 protein (FMRP) is produced (Kremer et al., 1991;
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Oberle et al., 1991; Yu et al., 1991; Verkerk et al., 1993;
Allingham-Hawkins et al., 1999). Almost 100% of the males
who inherited a full mutation show FXS that usually involves
intellectual disability, while only about 60% of the females
with a full mutation show mild to severe clinical features. It
is generally accepted that the FMR1 instability occurs when
the CGG repeats expanded beyond 55 CGG repeats; however,
instability in the normal range has also been documented
(Nolin et al., 2013). The full mutation occurs only when it is
transmitted from the mother; and it is rare for a contraction
to occur when the unstable expanded allele is passed on by the
mother (Lozano et al., 2016). Here, we described a rare case
of prenatal diagnosis of male fetus that inherited an allele that
contracted to a normal repeat size from the mother with the full
mutation.
MATERIALS AND METHODS
Subjects: Written informed consent was obtained from the
studied subjects for publication of this manuscript.
Allele categories were as described in Maddalena et al. (2001)
(normal 5–54 CGG, premutation alleles 55–200 CGG repeats, full
mutation alleles>200 CGG repeats).
A 40-year-old full mutation woman known to carry size
mosaicism for the presence of a premutation and a full mutation
alleles (29, 160, >200 CGG repeats) in the FMR1 gene was
referred to our laboratory for prenatal diagnosis of her 24-week
fetus. It was a spontaneous pregnancy after a long history of
failure in preimplantation genetic diagnosis (PGD) pregnancies.
The laboratory received 30 ml of amniotic fluid, which were
divided into two different syringes, and 5 ml was used for the
direct DNA extraction while the remaining amount was cultured
for karyotyping and DNA extraction.
Amniocytes Culture
The amniocytes were centrifuged and half of the pellet
suspended in CHANG medium (Irvine Scientific, Santa Ana, CA,
United States) while the other half was suspended in BioAMF-
2 (Biological Industries, Beit-HaEmek, Israel) and cultured in
25 cm flasks for 10–14 days. When cells reached confluence, they
were either harvested for DNA extraction or trypsinized for the
next passage. Cells harvested at the fifth and at seventh; by the
eighth passage, the culture failed.
Genomic DNA Extraction
Genomic DNA (gDNA) was extracted from peripheral blood
samples collected from the mother, the grandmother, and from
the father using QIAsymphony DNA Midi Kit (96)-931255 and
the QIAsymphony machine according to the manufacturer’s
instructions. Isolation of gDNA from cultures cells was carried
out using the QIAamp DNA blood Mini Kit-51104 (Qiagen,
Hilden, Germany) and the QIAsymphony machine according
to the manufacturer’s instructions. DNA was extracted from
amniotic fluid using the QIAamp DNA blood Micro Kit-56304
(Qiagen, Hilden, Germany), manually or using the QIAcube
machine according to the manufacturer’s instructions.
Triple-Primed FXS PCR
Genomic DNA (gDNA) (40–60 ng) was amplified with
the Amplidex FMR1 PCR assay (Asuragen, Austin, TX,
United States) as previously described (Nahhas et al., 2012) and
accordingly to the manufacturer’s instructions. Samples were
analyzed by the 3130xl Genetic Analyzer (Applied Biosystems
Inc., ABI, Foster City, CA, United States) and electropherograms
were analyzed using GeneMapper 4.0 (4.1 for 3500xL data)
(Filipovic-Sadic et al., 2010).
FMR1 5′ UTR Sequencing
Genomic DNA (gDNA) was amplified in 20 µl reaction
using forward primer FMR-C: 5′-GCTCAGCTCCGTTTCGG
TTTCACTTCCGGT-3′ and reverse primer FMR-F: 5′-AGC
CCCGCACTTCCACCACCAGCTCCTCCA-3′ (SIGMA). PCR
products were sequenced with BigDye Terminator v1.1 Cycle
Sequence Kit – Applied Biosystems – chemistry on a 3130xl
Genetic Analyzer (Life Technologies). Electropherograms were
analyzed using GeneMapper 4.0 (4.1 for 3500xL data).
Haplotype Analysis
Maternity studies were performed using Elucigene QSTR plus V2
kit. A segregation study was performed on the grandmother, the
mother, and the fetus using the following polymorphic makers:
DXS106, DXS8028, DXS998, FMR1: 146993469–147032647,
DXS106, DXS8069, DXS8061, DXS1073: and florescent primers
(Richards et al., 1991; Verkerk et al., 1993). Alleles were resolved
on capillary gel electrophoresis using ABI 3130xl apparatus.
Electropherograms were analyzed using GeneMapper 4.0 (4.1 for
3500xL data).
Methylation Analysis
Methylation analysis was carried out using the Amplidex FMR1
mPCR FMR1 kit (Asuragen, Austin, TX, United States) as
previously described by Chen et al. (2014). Briefly, two aliquots
of 40 ng gDNA isolated from the fetus, from a methylated
male control and from a normal male were prepared for
methylation assessment. One aliquot was mixed with 4 µL
Digestion Enzyme Mix (containing HhaI and AvaI), and the other
with 4 µL Digestion Control Mix (containing digestion buffer).
Aliquoted samples were incubated at 37◦C overnight. Following
digestion, aliquots from each sample analyzed according to
Asuragen’s instruction. The results were analyzed using the
3130xl Genetic Analyzer (Applied Biosystems Inc., ABI, Foster
City, CA, United States). Electropherograms were analyzed using
GeneMapper 4.0 (4.1 for 3500xL data) as described by Filipovic-
Sadic et al. (2010).
RESULTS
Capillary electrophoresis analysis of two different direct
amniocentesis samples of DNA revealed the presence of two
peaks: one less abundant [3000 relative fluorescent units (RFU)]
corresponding to 29 CGG repeat allele and the other much more
abundant peak (9000 RFU) corresponding to 19 CGG repeat
allele (Figure 1). Karyotype analysis confirmed a male fetus.
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FIGURE 1 | FMR1 mutation – length test. Electropherogram of the Asuragen test results showing the fetus (A) and the mother (B) CGG repeats length results. The
fetus results show presence of a pronounced peak at 19 CGG repeats (A) and the mother results (B) it shows normal allele with 29 CGG repeats and the unstable
allele with mosaicism, a premutation allele of 160 CGG repeats and full mutation greater than 200 CGG repeats.
DNA from eight amniocyte cultures was also tested: two
directly from cultured amniocytes, two from the first passage,
two from the fifth passage, and two from the seventh passage.
All samples showed presence of only the 19 CGG repeat
allele as observed in DNA isolated from the amniotic fluid
but without the less abundant peak corresponding to the
29 CGG repeat allele. The less abundant peak observed
from DNA isolated from amniotic fluid points to low level
of mother contamination, which can been detected by the
Amplidex PCR (Asuragen) as it has been proven to be much
more sensitive than other techniques (Filipovic-Sadic et al.,
2010; Tassone, 2015). None of the samples tested showed
evidence of an expanded allele excluding the possibility of
mosaicism.
Sequence analysis confirmed the presence of a 19 CGG repeat
allele in both DNA isolated from amniotic fluid and DNA isolated
from cultured amniocytes after seven passages (Figure 1). No
AGG interruptions were observed within the allele.
Testing the origin of the FMR1 allele by haplotype analysis
using the DNA derived from the mother, the fetus, and from
the maternal grandmother showed that the unstable allele
was transmitted from the grandmother to her daughter who
transmitted it to her male fetus; thus confirmed maternity
(Figure 2).
Methylation assay of the FMR1 gene using AvaI and HhaI
showed no methylation in the fetus cells while it showed
a normal methylation in both FMR1 alleles of the mother
suggesting that methylation assay is not reliable for fetal
cells.
DISCUSSION
The case described here represents a rare case of transmission
from a full mutation mother to her offspring with an allele pattern
different from what we would have expected in such cases. It is
a prenatal diagnosis case of a male fetus that inherited an allele
with a CGG repeats number in the normal size range (19 CGG
repeats) derived from the unstable expanded maternal allele (160,
>200 CGG repeats). It is well known that the majority (near to
100%) of the male fetuses that inherited unstable FMR1 allele
from mosaic mothers are expected to inherit a full mutation
allele. Contraction of a maternal high premutation (>100 CGG
repeats)/full mutation FMR1 allele during transmission has been
rarely described (Yrigollen et al., 2014; Miranda et al., 2015;
Tabolacci et al., 2016; Maia et al., 2017).
To our knowledge this is the first report of a prenatal diagnosis
case showing a pattern of contraction of an expanded FMR1
unstable allele to a normal size allele. Tabolacci et al. (2016)
previously described a case of a healthy 10-year-old boy who
inherited a contracted unstable FMR1 allele from his mother.
The authors described a family with a carrier mother (190 CGG
repeats) and her three children. Two of them presented with FXS
and had expanded alleles in the full mutation range (265–830
and 430–790 CGG repeats, respectively). In contrast, the healthy
boy inherited a contracted allele of 43 CGG repeats. Another
study (Maia et al., 2017) described four FXS boys carrying mosaic
alleles ranging from the normal (35, 26, 39, and 18 CGG repeats)
to the full mutation range (>200 CGG repeats). These studies
sharpen the obscure mechanism of expansion of the trinucleotide
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FIGURE 2 | Haplotype analysis for allele discrimination and tracing the origin
of FMR1 fetal allele. Haplotype analysis using the polymorphic makers:
DXS106, DXS8028, DXS998, FMR1: 146993469–147032647, DXS106,
DXS8069, DXS8061, DXS1073 shows that the unstable allele transmitted
from the grandmother to the mother and to her fetus.
repeat in the FMR1 gene, indicating that the same allele during
the generation might expand or contract and possibly undergo
methylation.
Since this is a prenatal diagnosis case, the questions are as
follows: Is the unstable allele contracted to the normal range
able to become a stable normal allele with no phenotypic
consequences? Is it a normal unstable allele that may lead to
some clinical involvement? Will it expand during transmission
in the following generations? Is it a case of mosaicism through an
undetected expanded allele of the FMR1 gene, which may cause
features of FXS?
It is of importance to understand the consequence of
contraction of high premutation/full mutation FMR1 allele as
understanding the mechanism of FMR1 instability can improve
genetic counseling of the family.
Although CGG instability within the FMR1 gene occurs
mainly from the premutation to the full mutation range,
instability on transmission with CGG repeat length, defined as
any measurable repeat change from the parent to the offspring,
has also been described in allele within the normal range (Nolin
et al., 2013). The magnitude of instability correlates to the
presence of AGG interruptions (Nolin et al., 2013; Yrigollen
et al., 2014). Normal alleles have an AGG interruption that
usually occurs after 9 or 10 CGG triplets (Yrigollen et al., 2014).
However, it has been found that increased instability seems to
be correlated with the presence of the first interruption at the
10th triplet (Gunter et al., 1998) and to the total number of
AGGs. The loss of AGGs occurs in a polarized way at the 3′-
end, creating a long pure (CGG)n with higher mutability (Kunst
and Warren, 1994; Limprasert et al., 2016). In the presented
case, the allele was a pure stretch of CGG without any AGG
interruption. The AGG interspersions in the CGG repeat region
are well known as an important element for stability of the
repeats (Ennis et al., 2007; Fernandez-Carvajal et al., 2009;
Carolyn et al., 2012; Nolin et al., 2013, 2015; Yrigollen et al.,
2014).
Sharony et al. (2012), Wakeling et al. (2014), and also our
laboratory (data not shown) experienced instability/mosaicism
in the normal–intermediate range (less than 55 CGG repeats).
Wakeling et al. (2014) reported that about 0.4% of the normal
population tested showed an extra allele. Our experience from
the routine FMR1 screening test of normal population as well
as the Sharony et al. (2012) study showed a lower frequency
of cases with an extra allele (12 out of 13,000 cases; data not
shown) in the normal range size. The presence of an extra allele
could be attributed to the presence of a cryptic duplication
event of the FMR1 locus (Mononen et al., 2007; Vengoechea
et al., 2012) of an early postzygotic expansion or contraction
of the FMR1 repeat tract or to a somatic instability of the
CGG tract. While somatic instability of premutation and full
mutation alleles is well documented (Cambouris et al., 1996;
Dobkin et al., 1996; Mingroni-Netto et al., 1996), information
regarding unstable normal alleles (Sullivan et al., 2005; Nolin
et al., 2011) is limited. In contrast to the report of Wakeling et al.
(2014), Maia et al. (2017) reported on four FXS mosaic males
carrying normal, premutated and full mutation FMR1 alleles. The
authors suggested that the normal allele of these patients resulted
from postzygotic contraction of the full expansion. The authors
study suggested the existence of a predisposing haplotype in the
population, which they named “risk lineage-specific haplotype,”
more prone to large contraction.
Although the mechanism(s) of the FMR1 instability are
still unknown, a mice model including the interplay among
components of the base excision repair, mismatch repair, and
transcription coupled repair pathways has been proposed (Zhao
et al., 2016). The authors indicated that expanded alleles are
unstable and can undergo to an expansion or contraction
event through different mechanisms. Contraction events have
been observed on both paternal and maternal transmission
although more frequently on paternal transmission (Nolin
et al., 2015). Although FMR1 expansion in human occurred
almost exclusively through maternal inheritance, there is no
reference to any sex factor. Contractions may derive from
simple strand slippage during replication or repair; however,
to date, which factors are involved in the processes of
repeat instability at the FMR1 locus remain an unanswered
question.
Although PCR-based approach and the sequencing tests
used in the present study have shown to be very reliable, we
cannot categorically exclude the presence of an expanded allele.
However, the results demonstrate the presence of a normal
size allele with no mosaicism, most likely leading to a normal
phenotype as the case described by Tabolacci et al. (2016).
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Our hypothesis is that the maternal premutation/full mutation
allele contracted pre-zygotically either in the mitotic or in the
meiotic stage resulting in a normal size allele in the fertilized egg
with no syndromic consequence.
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